Abbvie Stock Quote Today

ABBV -  USA Stock  

USD 150.43  2.00  1.31%

Market Performance
5 of 100
Odds Of Distress
Less than 32
Abbvie is selling for under 150.43 as of the 19th of May 2022; that is -1.31 percent decrease since the beginning of the trading day. The stock's lowest day price was 149.29. Abbvie has about a 32 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Abbvie Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of September 2021 and ending today, the 19th of May 2022. Click here to learn more.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. Abbvie operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. The company has 1.77 B outstanding shares of which 13.15 M shares are presently shorted by private and institutional investors with about 1.52 trading days to cover. More on Abbvie Inc
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Abbvie Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Abbvie's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Abbvie or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
The company currently holds 77.6 B in liabilities with Debt to Equity (D/E) ratio of 5.03, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Abbvie Inc has a current ratio of 0.77, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Abbvie until it has trouble settling it off, either with new capital or with free cash flow. So, Abbvie's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Abbvie Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Abbvie to invest in growth at high rates of return. When we think about Abbvie's use of debt, we should always consider it together with cash and equity.
Abbvie Inc has a strong financial position based on the latest SEC filings
About 70.0% of Abbvie shares are held by institutions such as insurance companies
Latest headline from investingnews.com: Investor Reminder Kessler Topaz Meltzer Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against AbbVie, Inc. - Investing News Network
Abbvie Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Abbvie Inc SEC Filings
Abbvie SEC Filings Security & Exchange Commission EDGAR Reports
ChairmanCarlos Alban  (View All)
Thematic Classifications
Active investing themes Abbvie currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
(view all).
Average Analyst Recommendation
Analysts covering Abbvie report their recommendations after researching Abbvie's financial statements, talking to executives and customers, or listening in on Abbvie's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Abbvie Inc. The Abbvie consensus assessment is calculated by taking the average forecast from all of the analysts covering Abbvie.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Abbvie Inc based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Abbvie Inc financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 7 - StrongDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares1.9 B1.8 B
Sufficiently Up
Increasing
Slightly volatile
Weighted Average Shares Diluted1.9 B1.8 B
Sufficiently Up
Increasing
Slightly volatile
Net Cash Flow from Operations18 B22.8 B
Significantly Down
Increasing
Slightly volatile
Total Assets116 B146.5 B
Significantly Down
Increasing
Slightly volatile
Total Liabilities105.4 B131.1 B
Significantly Down
Increasing
Slightly volatile
Current Assets26.7 B27.9 B
Sufficiently Down
Increasing
Slightly volatile
Current Liabilities38 B35.2 B
Significantly Up
Increasing
Slightly volatile
Total Debt62.5 B76.7 B
Significantly Down
Increasing
Slightly volatile
Return on Average Assets0.08740.078
Moderately Up
Decreasing
Slightly volatile
Gross Margin0.680.69
Fairly Down
Decreasing
Slightly volatile
Asset Turnover0.430.379
Moderately Up
Decreasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Abbvie's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong BuyUndervalued
Financial Strength
Abbvie's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Abbvie's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Abbvie's financial leverage. It provides some insight into what part of Abbvie's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Abbvie's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Abbvie deploys its capital and how much of that capital is borrowed.
Liquidity
Abbvie cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 77.6 B in liabilities with Debt to Equity (D/E) ratio of 5.03, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Abbvie Inc has a current ratio of 0.77, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Abbvie until it has trouble settling it off, either with new capital or with free cash flow. So, Abbvie's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Abbvie Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Abbvie to invest in growth at high rates of return. When we think about Abbvie's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

17.99 BillionShare
Abbvie Inc (ABBV) is traded on New York Stock Exchange in USA. It is located in 1 North Waukegan Road and employs 50,000 people. Abbvie is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with current market capitalization of 273.63 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abbvie's market, we take the total number of its shares issued and multiply it by Abbvie's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Abbvie Inc conducts business under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.77 B outstanding shares of which 13.15 M shares are presently shorted by private and institutional investors with about 1.52 trading days to cover. Abbvie Inc currently holds about 9.83 B in cash with 22.78 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.56.
Check Abbvie Probability Of Bankruptcy
Ownership
Abbvie Inc retains a total of 1.77 Billion outstanding shares. The majority of Abbvie Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Abbvie Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Abbvie. Please pay attention to any change in the institutional holdings of Abbvie Inc as this could imply that something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Abbvie Ownership Details

Abbvie Stock Price Odds Analysis

What are Abbvie's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Abbvie jumping above the current price in 90 days from now is about 70.22%. The Abbvie Inc probability density function shows the probability of Abbvie stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Abbvie has a beta of 0.4405. This suggests as returns on the market go up, Abbvie average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Abbvie Inc will be expected to be much smaller as well. Additionally, the company has an alpha of 0.1743, implying that it can generate a 0.17 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 150.43HorizonTargetOdds Above 150.43
29.56%90 days
 150.43 
70.22%
Based on a normal probability distribution, the odds of Abbvie to move above the current price in 90 days from now is about 70.22 (This Abbvie Inc probability density function shows the probability of Abbvie Stock to fall within a particular range of prices over 90 days) .

Abbvie Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Abbvie that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Abbvie's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Abbvie's value.
InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares150.5 M24.4 B
Blackrock IncCommon Shares129.6 M21 B
View Abbvie Diagnostics

Abbvie Historical Income Statement

Abbvie Inc Income Statement is one of the three primary financial statements used for reporting Abbvie's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Abbvie Inc revenue and expense. Abbvie Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Abbvie Direct Expenses is fairly stable at the moment as compared to the past year. Abbvie reported Direct Expenses of 13.85 Billion in 2021. Cost of Revenue is likely to climb to about 18.8 B in 2022, whereas Earning Before Interest and Taxes EBIT is likely to drop slightly above 12.3 B in 2022. View More Fundamentals

Abbvie Stock Against Markets

Picking the right benchmark for Abbvie stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Abbvie stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Abbvie is critical whether you are bullish or bearish towards Abbvie Inc at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Abbvie without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Competition Analyzer Now

   

Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module

Abbvie Corporate Directors

Abbvie corporate directors refer to members of an Abbvie board of directors. The board of directors generally takes responsibility for the Abbvie's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Abbvie's board members must vote for the resolution. The Abbvie board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Brett Hart - Independent DirectorProfile
Roxanne Austin - Independent DirectorProfile
Edward Rapp - Independent DirectorProfile
Frederick Waddell - Independent DirectorProfile

Investing Abbvie Inc

You need to understand the risk of investing before taking a position in Abbvie. The danger of trading Abbvie Inc is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Abbvie is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Abbvie. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Abbvie Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Abbvie Inc information on this page should be used as a complementary analysis to other Abbvie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Abbvie Stock analysis

When running Abbvie Inc price analysis, check to measure Abbvie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbvie is operating at the current time. Most of Abbvie's value examination focuses on studying past and present price action to predict the probability of Abbvie's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbvie's price. Additionally, you may evaluate how the addition of Abbvie to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Is Abbvie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbvie. If investors know Abbvie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbvie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Abbvie Inc is measured differently than its book value, which is the value of Abbvie that is recorded on the company's balance sheet. Investors also form their own opinion of Abbvie's value that differs from its market value or its book value, called intrinsic value, which is Abbvie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbvie's market value can be influenced by many factors that don't directly affect Abbvie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbvie's value and its price as these two are different measures arrived at by different means. Investors typically determine Abbvie value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbvie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.